Network pharmacology and molecular docking analysis of Catharanthus roseus compounds: Implications for non-small cell lung cancer treatment

被引:2
|
作者
Alsaif, Ghaida [1 ,2 ]
Tasleem, Munazzah [3 ]
Rezgui, Raja [1 ]
Alshaghdali, Khalid [1 ,2 ]
Saeed, Amir [1 ,4 ,5 ]
Saeed, Mohd [4 ]
机构
[1] Univ Hail, Coll Appl Med Sci, Dept Clin Lab Sci, Hail 55473, Saudi Arabia
[2] Univ Hail, Med & Diagnost Res Ctr, Hail 55473, Saudi Arabia
[3] Jamia Hamdard, Dept Biochem, Delhi, India
[4] Univ Hail, Coll Sci, Dept Biol, Hail 55473, Saudi Arabia
[5] Univ Med Sci & Technol, Fac Med Lab Sci, Dept Med Microbiol, Khartoum, Sudan
关键词
Catharanthus roseus; BCL-2; receptor; Non -small cell lung cancer (NSCLC); Network pharmacology; Molecular docking;
D O I
10.1016/j.jksus.2024.103134
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The prevalence of non-small cell lung cancer (NSCLC), particularly in the Eastern Region of Saudi Arabia, is concerning and highlights the need for novel treatments, despite recent progress in NSCLC treatment. Plantderived natural compounds, such as those found in Catharanthus roseus, have shown promising results in cancer research. By employing cutting-edge computational analysis techniques, such as molecular docking and network pharmacology, the study aimed to understand the mechanism of action of compounds isolated from C. roseus. The study identified several bioactive and drug-like compounds in C. roseus that displayed diverse interactions with important proteins associated with cancer. The compounds PubChem CIDs 5316490, 425978, and 261578 were found to form significant interactions within the binding site of the B-cell-lymphoma-2 (BCL-2) protein. Compound 5316490, in particular, interacted with critical residues within the target protein, highlighting its potential as a therapeutic agent against lung cancer. The understanding of the molecular targets and mechanism of action of C. roseus bioactive compounds obtained from this study provides hope for improving current treatment options. In conclusion, the findings provide additional details on the evidence supporting the potential of C. roseus as a treatment for NSCLC and suggest that further research could lead to the development of innovative, potent therapies.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Shan Ci Gu (Cremastra appendiculata) Against Non-Small Cell Lung Cancer
    Wang, Yan
    Zhang, Yunwu
    Wang, Yujia
    Shu, Xinyao
    Lu, Chaorui
    Shao, Shiliang
    Liu, Xingting
    Yang, Cheng
    Luo, Jingsong
    Du, Quanyu
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [22] Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer
    Kangwook Lee
    Yu-Jeong Choi
    Hae-In Lim
    Kwang Jin Cho
    Nuri Kang
    Seong-Gyu Ko
    BMC Complementary Medicine and Therapies, 24
  • [23] Molecular treatment stratification of non-small cell lung cancer
    Lang, Susanne M.
    Rachow, Tobias
    ONKOLOGE, 2020, 26 (08): : 727 - 735
  • [24] Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer
    Lee, Kangwook
    Choi, Yu-Jeong
    Lim, Hae-In
    Cho, Kwang Jin
    Kang, Nuri
    Ko, Seong-Gyu
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [25] Network pharmacology study of Citrus reticulata and Pinellia ternata in the treatment of non-small cell lung cancer
    Li, Changyang
    Lu, Hongxiu
    Jiang, Xianghu
    Guo, Xuefeng
    Zhong, Hua
    Li, Huijie
    CELLULAR AND MOLECULAR BIOLOGY, 2021, 67 (04) : 10 - 17
  • [26] Analysis of signaling network in non-small cell lung cancer
    Liu Wei
    Ye Fei
    Li Guanghu
    Wu Yong
    Wang Libo
    Glaser, Laurel
    Yin Guanghao
    Xue Menghua
    Zhu Dongshan
    Zhang, David Y.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S628 - S628
  • [27] MOLECULAR INEQUALITY IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) AND IMPLICATIONS FOR CLINICAL TRIALS
    Naidoo, Jarushka
    Noonan, Sinead
    Teo, Min Yuen
    Rho, Young Soo
    Clince, Janet
    Gately, Kathy
    O'Grady, Tony
    Kaye, Elaine
    Calvert, Paula
    Morris, Patrick G.
    O'Brien, Cathal
    O'Byrne, Kenneth
    Breathnach, Oscar S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1208 - S1208
  • [28] Treatment Delays in Non-small Cell Lung Cancer and Their Prognostic Implications
    Diaconescu, Razvan
    Lafond, Chantal
    Whittom, Renaud
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1254 - 1259
  • [29] Molecular mechanisms of phytoconstituents from selected Egyptian plants against non-small cell lung cancer using integrated in vitro network pharmacology and molecular docking approach
    Shaala, Lamiaa A.
    Youssef, Diaa T. A.
    Ramadan, Mahmoud A.
    Khalifa, Azza A.
    Ibrahim, Reham S.
    Valeriote, Fred
    Celik, Ismail
    Dawood, Hend M.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [30] Oral vinorelbine: Pharmacology and results in the treatment of non-small cell lung cancer and breast cancer
    Bartsch, V
    ONKOLOGIE, 2006, 29 : 1 - 28